Article
Association of MDM2 T309G (rs2279744) Polymorphism and Expression Changes With Risk of Prostate Cancer in the Slovak Population.
Anticancer research - 1 Nov 2020
Sivonova Monika Kmetova, Jurecekova Jana, Kaplan Peter, Hives Mark, Grendar Marian, Tomascova Anna, Dusenka Robert, Drobkova Henrieta, Evin Daniel, Kliment Jan
Abstract excerpt
BACKGROUND/AIM: The aim of this study was to evaluate the relationship between MDM2 T309G polymorphism and prostate cancer risk in the Slovak population and the association of this polymorphism with MDM2 expression and clinicopathological features. MATERIALS AND METHODS: The MDM2 T309G polymorphism was determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis in 506...
Topics
- Aged
- Case-Control Studies
- Gene Expression Regulation, Neoplastic
- Gene Frequency
- Genetic Association Studies
- Genetic Predisposition to Disease
- Humans
- Male
- Polymorphism, Single Nucleotide
